The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 9, 2026 | Pavao Mark H | Director | Grant(A) | 10K | — | $0 |
| Jan 22, 2026 | Swaminathan Arun | Chief Executive Officer, Director | Grant(A) | 294K | — | $0 |
| Jan 22, 2026 | Berman Howard | Executive Chairman, Director | Grant(A) | 15K | — | $0 |
| Jan 22, 2026 | Grossman Fred | Chief Medical Officer | Grant(A) | 140K | — | $0 |
| Jan 22, 2026 | Snyder David S | Chief Financial Officer | Grant(A) | 140K | — | $0 |
| Jan 2, 2026 | Lee Ann | Director | Grant(A) | 10K | — | $0 |
| Jan 2, 2026 | Ross Wilbur L JR | Director | Grant(A) | 10K | — | $0 |
| Jan 2, 2026 | Weinand Dieter | Director | Grant(A) | 10K | — | $0 |
| Jan 2, 2026 | Goldstein Dov A MD | Director | Grant(A) | 10K | — | $0 |
| Jan 2, 2026 | Villalobos Anabella | Director | Grant(A) | 10K | — | $0 |
| Aug 18, 2025 | Goldstein Dov A MD | Director | Option exercise(M) | 18K | $1.09 | $19K |
| Aug 18, 2025 | Goldstein Dov A MD | Director | Option exercise(M) | 18K | — | $0 |
| Feb 25, 2025 | Ross Wilbur L JR | Director | Grant(A) | 5K | — | $0 |
| Feb 25, 2025 | Weinand Dieter | Director | Grant(A) | 5K | — | $0 |
| Feb 25, 2025 | Goldstein Dov A MD | Director | Grant(A) | 5K | — | $0 |
| Feb 25, 2025 | Villalobos Anabella | Director | Grant(A) | 5K | — | $0 |
| Feb 25, 2025 | Lee Ann | Director | Grant(A) | 5K | — | $0 |
| Jan 9, 2025 | Berman Howard | Director | Grant(A) | 151K | — | $0 |
| Jan 9, 2025 | Grossman Fred | Chief Medical Officer | Grant(A) | 141K | — | $0 |
| Jan 9, 2025 | Swaminathan Arun | Chief Executive Officer, Director | Grant(A) | 241K | — | $0 |
| Jan 9, 2025 | Snyder David S | Chief Financial Officer | Grant(A) | 141K | — | $0 |
| Jan 1, 2025 | Weinand Dieter | Director | Grant(A) | 5K | — | $0 |
| Jan 1, 2025 | Villalobos Anabella | Director | Grant(A) | 5K | — | $0 |
| Jan 1, 2025 | Lee Ann | Director | Grant(A) | 5K | — | $0 |
| Jan 1, 2025 | Ross Wilbur L JR | Director | Grant(A) | 5K | — | $0 |
| Jan 1, 2025 | Goldstein Dov A MD | Director | Grant(A) | 5K | — | $0 |
| Nov 14, 2024 | Snyder David S | Chief Financial Officer | Buy(P) | 2K | $7.19 | $13K |
| Nov 13, 2024 | Swaminathan Arun | Chief Executive Officer, Director | Buy(P) | 5K | $7.36 | $37K |
| Nov 11, 2024 | Swaminathan Arun | Chief Executive Officer, Director | Buy(P) | 5K | $7.34 | $37K |
| Nov 11, 2024 | Grossman Fred | Chief Medical Officer | Buy(P) | 3K | $7.37 | $20K |
| Jun 3, 2024 | Grossman Fred | Chief Medical Officer | Grant(A) | 71K | — | $0 |
| Jun 3, 2024 | Berman Howard | Chief Executive Officer, Director | Grant(A) | 164K | — | $0 |
| Jun 3, 2024 | Snyder David S | Chief Financial Officer | Grant(A) | 71K | — | $0 |
| Jan 31, 2024 | Grossman Fred | Chief Medical Officer | Grant(A) | 74K | — | $0 |
| Jan 31, 2024 | Grossman Fred | Chief Medical Officer | Grant(A) | 82K | — | $0 |
| Jan 31, 2024 | Berman Howard | Chief Executive Officer, Director | Grant(A) | 190K | — | $0 |
| Jan 31, 2024 | Snyder David S | Chief Financial Officer | Grant(A) | 82K | — | $0 |
| Jan 2, 2024 | Ross Wilbur L JR | Director | Grant(A) | 10K | — | $0 |
| Jan 1, 2024 | Villalobos Anabella | Director | Grant(A) | 5K | — | $0 |
| Jan 1, 2024 | Lee Ann | Director | Grant(A) | 5K | — | $0 |
| Jan 1, 2024 | Weinand Dieter | Director | Grant(A) | 5K | — | $0 |
| Jan 1, 2024 | Goldstein Dov A MD | Director | Grant(A) | 5K | — | $0 |
| Jan 1, 2024 | Garren Hideki | Director | Grant(A) | 5K | — | $0 |
| Aug 22, 2023 | Lee Ann | Director | Buy(P) | 1K | $3.62 | $4K |
| Aug 18, 2023 | Weinand Dieter | Director | Grant(A) | 10K | — | $0 |
| Jul 17, 2023 | Grossman Fred | Chief Medical Officer | Grant(A) | 74K | — | — |
| Feb 27, 2023 | Snyder David S | Chief Financial Officer | Grant(A) | 115K | — | $0 |
| Feb 27, 2023 | Hepner Adrian | Chief Medical Officer | Grant(A) | 115K | — | $0 |
| Feb 27, 2023 | Berman Howard | Chief Executive Officer, Director | Grant(A) | 165K | — | $0 |
| Jan 3, 2023 | Goldstein Dov A MD | Director | Buy(P) | 10K | — | — |
| Jan 3, 2023 | Goldstein Dov A MD | Director | Buy(P) | 5K | — | — |
| Jan 3, 2023 | Villalobos Anabella | Director | Buy(P) | 10K | — | — |
| Jan 3, 2023 | Villalobos Anabella | Director | Buy(P) | 5K | — | — |
| Jan 3, 2023 | Garren Hideki | Director | Buy(P) | 2K | — | — |
| Jan 3, 2023 | Garren Hideki | Director | Buy(P) | 1K | — | — |
| Jan 3, 2023 | Snyder David S | Chief Financial Officer | Buy(P) | 7K | — | — |
| Jan 3, 2023 | Snyder David S | Chief Financial Officer | Buy(P) | 4K | — | — |
| Jan 3, 2023 | Hepner Adrian | Chief Medical Officer | Buy(P) | 10K | — | — |
| Jan 3, 2023 | Hepner Adrian | Chief Medical Officer | Buy(P) | 5K | — | — |
| Jan 3, 2023 | Lee Ann | Director | Buy(P) | 10K | — | — |
| Jan 3, 2023 | Lee Ann | Director | Conversion(C) | 6K | $4.00 | $26K |
| Jan 3, 2023 | Lee Ann | Director | Conversion(C) | 0 | — | $0 |
| Jan 3, 2023 | Lee Ann | Director | Buy(P) | 5K | — | — |
| Jan 3, 2023 | Berman Howard | Chief Executive Officer, Director, 10% Owner | Buy(P) | 10K | — | — |
| Jan 3, 2023 | Berman Howard | Chief Executive Officer, Director, 10% Owner | Buy(P) | 5K | — | — |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).